Age of onset may affect clinical outcomes for multiple sclerosis patients on disease-modifying therapy
Age of onset for disease is an important factor affecting clinical outcomes across the life span in patients receiving disease-modifying therapy (DMT) for multiple sclerosis (MS), according to a study published online Feb. ...
Mar 2, 2020
0
1